Who owns LQDA
241 institutions reported holding LQDA for 2026Q1, together 61% of the company, more than the 226 a quarter earlier.
241
Institutions reporting a position · as of 2026Q1 · up from 226 the quarter before
- Shares held by institutions
- 61.5M
Shares held by institutions · 61% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $2.31B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 30%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 31
- New positions
- 47
- Positions exited
- 37
- Added to
- 72
- Reduced
- 75
- Top 10 holdersof the company
- 39%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 241 | 61.5M | $2.31B |
| 2025Q4 | 226 | 61.9M | $2.13B |
| 2025Q3 | 199 | 64.6M | $1.48B |
| 2025Q2 | 175 | 57.4M | $716M |
| 2025Q1 | 168 | 54.7M | $808M |
| 2024Q4 | 164 | 51.3M | $623M |
| 2024Q3 | 154 | 52.6M | $526M |
| 2024Q2 | 137 | 46.4M | $556M |
| 2024Q1 | 139 | 46.2M | $682M |
| 2023Q4 | 115 | 35.7M | $429M |
| 2023Q3 | 102 | 28.6M | $184M |
| 2023Q2 | 101 | 29.1M | $229M |
| 2023Q1 | 92 | 29.5M | $207M |
| 2022Q4 | 85 | 29.5M | $194M |
| 2022Q3 | 89 | 21.0M | $114M |
| 2022Q2 | 80 | 23.0M | $100M |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 8.7M | 8.6% | $327M |
| Caligan Partners LP | 8.1M | 8.0% | $306M |
| BlackRock Inc. | 5.5M | 5.4% | $207M |
| VANGUARD GROUP INC | 4.1M | 4.1% | $156M |
| FINDELL CAPITAL MANAGEMENT LLC | 3.5M | 3.5% | $132M |
| Opaleye Management Inc. | 2.5M | 2.5% | $89M |
| BANK OF AMERICA CORP /DE/ | 2.3M | 2.3% | $86M |
| GEODE CAPITAL MANAGEMENT LLC | 1.9M | 1.9% | $73M |
| STATE STREET CORP | 1.9M | 1.9% | $71M |
| MPM BIOIMPACT LLC | 1.4M | 1.4% | $53M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #17 of 28 by Smart Score